151 related articles for article (PubMed ID: 38530923)
1. Epistasis Between HLA-DRB1*16:02:01 and SLC16A11 T-C-G-T-T Reduces Odds for Type 2 Diabetes in Southwest American Indians.
Williams RC; Hanson RL; Peters B; Kearns K; Knowler WC; Bogardus C; Baier LJ
Diabetes; 2024 Jun; 73(6):1002-1011. PubMed ID: 38530923
[TBL] [Abstract][Full Text] [Related]
2. Analysis of SLC16A11 Variants in 12,811 American Indians: Genotype-Obesity Interaction for Type 2 Diabetes and an Association With RNASEK Expression.
Traurig M; Hanson RL; Marinelarena A; Kobes S; Piaggi P; Cole S; Curran JE; Blangero J; Göring H; Kumar S; Nelson RG; Howard BV; Knowler WC; Baier LJ; Bogardus C
Diabetes; 2016 Feb; 65(2):510-9. PubMed ID: 26487785
[TBL] [Abstract][Full Text] [Related]
3. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.
; Williams AL; Jacobs SB; Moreno-Macías H; Huerta-Chagoya A; Churchhouse C; Márquez-Luna C; García-Ortíz H; Gómez-Vázquez MJ; Burtt NP; Aguilar-Salinas CA; González-Villalpando C; Florez JC; Orozco L; Haiman CA; Tusié-Luna T; Altshuler D
Nature; 2014 Feb; 506(7486):97-101. PubMed ID: 24390345
[TBL] [Abstract][Full Text] [Related]
4. The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes.
Kimura Y; Higuchi I; Kobayashi M; Furugen A; Narumi K; Suzuki Y; Miyoshi H; Nakamura A; Atsumi T; Iseki K
Drug Metab Pharmacokinet; 2021 Apr; 37():100376. PubMed ID: 33561739
[TBL] [Abstract][Full Text] [Related]
5. Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes.
Lara-Riegos JC; Ortiz-López MG; Peña-Espinoza BI; Montúfar-Robles I; Peña-Rico MA; Sánchez-Pozos K; Granados-Silvestre MA; Menjivar M
Gene; 2015 Jul; 565(1):68-75. PubMed ID: 25839936
[TBL] [Abstract][Full Text] [Related]
6. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
Almeda-Valdes P; Gómez Velasco DV; Arellano Campos O; Bello-Chavolla OY; Del Rocío Sevilla-González M; Viveros Ruiz T; Martagón Rosado AJ; Bautista CJ; Muñoz Hernandez L; Cruz-Bautista I; Moreno-Macias H; Huerta-Chagoya A; Rodríguez-Álvarez KG; Walford GA; Jacobs SBR; Guillen Pineda LE; Ordoñez-Sánchez ML; Roldan-Valadez E; Azpiroz J; Furuzawa-Carballeda J; Clark P; Herrera-Hernández MF; Zambrano E; Florez JC; Tusié Luna MT; Aguilar-Salinas CA
Eur J Endocrinol; 2019 Feb; 180(2):99-107. PubMed ID: 30475225
[TBL] [Abstract][Full Text] [Related]
7. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.
Rusu V; Hoch E; Mercader JM; Tenen DE; Gymrek M; Hartigan CR; DeRan M; von Grotthuss M; Fontanillas P; Spooner A; Guzman G; Deik AA; Pierce KA; Dennis C; Clish CB; Carr SA; Wagner BK; Schenone M; Ng MCY; Chen BH; ; ; Centeno-Cruz F; Zerrweck C; Orozco L; Altshuler DM; Schreiber SL; Florez JC; Jacobs SBR; Lander ES
Cell; 2017 Jun; 170(1):199-212.e20. PubMed ID: 28666119
[TBL] [Abstract][Full Text] [Related]
8. HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype.
Howson JM; Roy MS; Zeitels L; Stevens H; Todd JA
Diabet Med; 2013 Jun; 30(6):710-6. PubMed ID: 23398374
[TBL] [Abstract][Full Text] [Related]
9. Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Hidalgo BA; Sofer T; Qi Q; Schneiderman N; Chen YI; Kaplan RC; Avilés-Santa ML; North KE; Arnett DK; Szpiro A; Cai J; Yu B; Boerwinkle E; Papanicolaou G; Laurie CC; Rotter JI; Stilp AM
Sci Rep; 2019 Jan; 9(1):843. PubMed ID: 30696834
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
Qi J; Wang TJ; Li HX; Wu D; Du D; Wu JH; Shang LX; Chen L; Wang MN; Wang XF
Hum Immunol; 2020 Dec; 81(12):685-691. PubMed ID: 32693929
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
Scally SW; Law SC; Ting YT; Heemst JV; Sokolove J; Deutsch AJ; Bridie Clemens E; Moustakas AK; Papadopoulos GK; van der Woude D; Smolik I; Hitchon CA; Robinson DB; Ferucci ED; Bernstein CN; Meng X; Anaparti V; Huizinga T; Kedzierska K; Reid HH; Raychaudhuri S; Toes RE; Rossjohn J; El-Gabalawy H; Thomas R
Ann Rheum Dis; 2017 Nov; 76(11):1915-1923. PubMed ID: 28801345
[TBL] [Abstract][Full Text] [Related]
12. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease.
Koeleman BP; Lie BA; Undlien DE; Dudbridge F; Thorsby E; de Vries RR; Cucca F; Roep BO; Giphart MJ; Todd JA
Genes Immun; 2004 Aug; 5(5):381-8. PubMed ID: 15164102
[TBL] [Abstract][Full Text] [Related]
13. Analysis of two susceptibility SNPs in HLA region and evidence of interaction between rs6457617 in HLA-DQB1 and HLA-DRB1*04 locus on Tunisian rheumatoid arthritis.
Achour Y; Ben Hamad M; Chaabane S; Rebai A; Marzouk S; Mahfoudh N; Bahloul Z; Keskes L; Maalej A
J Genet; 2017 Dec; 96(6):911-918. PubMed ID: 29321349
[TBL] [Abstract][Full Text] [Related]
14. The influence of the HLA-DRB, HLA-DQB and polymorphic positions of the HLA-DRβ1 and HLA-DQβ1 molecules on risk of Iranian type 1 diabetes mellitus patients.
Sayad A; Akbari MT; Pajouhi M; Mostafavi F; Zamani M
Int J Immunogenet; 2012 Oct; 39(5):429-36. PubMed ID: 22494469
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
Oka S; Furukawa H; Yasunami M; Kawasaki A; Nakamura H; Nakamura M; Komori A; Abiru S; Nagaoka S; Hashimoto S; Naganuma A; Naeshiro N; Yoshizawa K; Yamashita H; Ario K; Ohta H; Sakai H; Yabuuchi I; Takahashi A; Abe K; Yatsuhashi H; Tohma S; Ohira H; Tsuchiya N; Migita K
PLoS One; 2017; 12(10):e0187325. PubMed ID: 29088299
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in the
Mardones L; Petermann-Rocha F; Martinez-Sanguinetti MA; Leiva AM; Troncoso-Pantoja C; Martorell M; Lasserre N; Ulloa N; Perez-Bravo F; Celis-Morales C; Villagran M;
Arch Endocrinol Metab; 2021 Nov; 65(3):305-314. PubMed ID: 33909378
[TBL] [Abstract][Full Text] [Related]
17. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.
Agliardi C; Guerini FR; Saresella M; Caputo D; Leone MA; Zanzottera M; Bolognesi E; Marventano I; Barizzone N; Fasano ME; Al-Daghri N; Clerici M
Brain Behav Immun; 2011 Oct; 25(7):1460-7. PubMed ID: 21664963
[TBL] [Abstract][Full Text] [Related]
19. Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data.
Hoch E; Florez JC; Lander ES; Jacobs SBR
Cell Rep; 2019 Oct; 29(3):778-780. PubMed ID: 31618643
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA class II alleles/haplotypes and amino acid variations in the peptide binding pockets with rheumatoid arthritis.
Chinniah R; Rajendran MS; Sivanadham R; Adaikalam ML; Ravi PM; Vijayan M; Boopathy S; Pandi S; Sevak V; Karuppiah B
Int J Rheum Dis; 2019 Aug; 22(8):1553-1562. PubMed ID: 31169355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
